Results 161 to 170 of about 63,797 (281)

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

Annals of the Rheumatic Diseases, 2008
G. Ruiz‐Irastorza, M. Ramos-Casals, P. Brito-Zerón, M. Khamashta   +3 more
semanticscholar   +1 more source

Reducing inequities in access to postpartum hemorrhage prevention: Reframing advance distribution of misoprostol as a test case for health system responsiveness and adaptation

International Journal of Gynecology &Obstetrics, Volume 172, Issue S2, Page S26-S33, June 2026.
Abstract Advance distribution of misoprostol is an evidence‐based strategy for preventing postpartum hemorrhage (PPH) at births without skilled health personnel present. Despite its lifesaving potential, initial momentum behind this intervention has slowed over the last decade and has not been renewed since WHO released updated guidelines in 2020 or ...
Hannah Tappis, Naoko Doi, Chirag Bhola, Yapouloucé Bamba, Eva Lathrop   +4 more
wiley   +1 more source

Disease course, comorbidities, and treatment outcomes of lupus erythematosus panniculitis in adults and children: A retrospective review. [PDF]

JAAD Int
Obiakor B, Abegaze B, Feng AS, Haemel A.
europepmc   +1 more source

N6‐Methyladenosine (m6A) in Liver Disease: Pathogenic Mechanisms and Therapeutic Potential

iNew Medicine, Volume 2, Issue 2, June 2026.
ABSTRACT Accumulating evidence highlights the critical role of epigenetic modifications, particularly N6‐methyladenosine (m6A), in liver disease. As the most abundant RNA modification in eukaryotic cells, m6A is dynamically regulated by multicomponent m6A methyltransferases (e.g., METTL3 and METTL14), demethylases (FTO and ALKBH5), and m6A‐binding ...
Yingfen Chen, Ru Ya, Ziling Zhang, Siyue Dong, Seol Hee Park, Wonhyo Seo, Yong He   +6 more
wiley   +1 more source

Using sentinel surveillance system data to characterize severe malaria illness and quality of malaria case management among hospitalized patients in Kenya, 2017-2024. [PDF]

Malar J
Itoh M, Lucchi N, Schultz J, Agogo GO, Munyua P, Chege D, Mwenda DN, Akoth S, Sumbi V, Shieshia M, Kandie R, Onyango EO, Hines JZ.   +12 more
europepmc   +1 more source

Long‐Term Dermoscopic Evolution of Reticular Erythematous Mucinosis: Case Report

JEADV Clinical Practice, Volume 5, Issue 2, Page 637-639, June 2026.
ABSTRACT Reticular erythematous mucinosis is a rare dermatosis with a challenging diagnosis. To date, its dermoscopic features have not been well characterised in the literature. Only a limited number of case reports have described dermoscopic findings that may be indicative of the disorder, including the presence of dotted and linear vessels, as well ...
Grażyna Kamińska‐Winciorek, Karolina Zarańska, Anastazja Szlauer‐Stefańska, Jacek Pająk, Sebastian Giebel   +4 more
wiley   +1 more source

Designing novel bisquinoline antimalarials from historical 4-aminoquinolines to combat drug-resistant malaria. [PDF]

Antimicrob Agents Chemother
Handford MJ, Li Y, Riscoe T, Zhang X, Kelly JX, Riscoe MK.   +5 more
europepmc   +1 more source

Antimalarial cabamiquine inhibits blood-stage of different field isolates of Plasmodium species. [PDF]

BMC Infect Dis
Dembele L, Aniweh Y, Soulama A, Sogore F, Diakité O, Diallo F, Dao F, Amenga-Etego LN, Demarta-Gatsi C, Spangenberg T, Djimde AA.   +10 more
europepmc   +1 more source

A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs.

Journal of Antimicrobial Chemotherapy, 2015
J. Bolscher, Karin M. J. Koolen, G. V. Gemert, M. Vegte-Bolmer, T. Bousema, D. Leroy, R. Sauerwein, K. Dechering   +7 more
semanticscholar   +1 more source

Successful Use of Bimekizumab in Refractory Acute Generalised Exanthematous Pustulosis Triggered by Amoxicillin‐Clavulanate

JEADV Clinical Practice, Volume 5, Issue 2, Page 669-672, June 2026.
ABSTRACT Acute generalised exanthematous pustulosis (AGEP) is a rare, acute neutrophilic dermatosis most commonly triggered by drugs, which typically resolves within 2 weeks following withdrawal of the causative agent. Topical and systemic corticosteroids remain the standard treatment.
Alexandra Junge, Charlotte Vogel, Theresa Hempel, Basil Signer, Nikhil Yawalkar, Kristine Heidemeyer   +5 more
wiley   +1 more source